全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:... Jerome Schlue , Hans Kreipe , Ulrich Lehmann
来源:[J].The Journal of Molecular Diagnostics(IF 3.952), 2020
摘要:Chromosomal translocations resulting in fusion genes represent important oncogenic drivers and potential therapeutic targets in rare leukemia subtypes. Formalin-fixed, paraffin-embedded trephines are frequently used in hematologic diagnostic tests and provide relevant access to l...
作者:... Marianne Tinguely , Hans Kreipe , Matthias Christgen
来源:[J].Pathology - Research and Practice(IF 1.213), 2019, Vol.215 (11)
摘要:Abstract(#br)Lobular neoplasia (LN), invasive lobular breast cancer (ILBC) and related pleomorphic variants represent a distinct group of neoplastic mammary gland lesions. This study assessed the inter-observer agreement of histological grading in a series of ILBC and LN.(#b...
作者:... Britta Hasemeier , Hans Kreipe , Ulrich Lehmann
来源:[J].Experimental and Molecular Pathology(IF 2.128), 2018, Vol.105 (1), pp.37-40
摘要:Abstract(#br)The detection of hotspot mutations in key cancer genes is now an essential part of the diagnostic work-up in molecular pathology. Nearly all assays for mutation detection involve an amplification step. A second single nucleotide variant (SNV) on the same allele adjac...
作者:... Richard Arnold , Hans Kreipe , Henning Feist
来源:[J].Placenta(IF 3.117), 2019, Vol.78, pp.23-28
摘要:Abstract(#br)Introduction(#br)Chronic histiocytic intervillositis of unknown etiology (CIUE) is a non-infectious, most probably immunologic placenta lesion. CIUE is associated with recurrent miscarriage, intrauterine growth restriction and stillbirth. Among the pathologic-an...
作者:Hans Kreipe , Florian Länger ...
来源:[J].Pathology - Research and Practice(IF 1.213), 2017, Vol.213 (12), pp.1530-1535
摘要:Abstract(#br)Background(#br)EGFR and its downstream signaling pathway are important targets for cancer therapy. Recently, the monoclonal anti-EGFR antibody Necitumumab in combination with gemcitabine and cisplatin was approved (EMA/14106/2016) for first-line treatment of squ...
作者:... Elisa Schipper , Hans Kreipe , Ulrich Lehmann
来源:[J].The Journal of Molecular Diagnostics(IF 3.952), 2017, Vol.19 (5), pp.722-732
摘要:Circulating cell-free DNA (cfDNA), which is isolated from blood plasma, represents a noninvasive source for the detection of mutations conferring resistance against epidermal growth factor receptor ( EGFR ) tyrosine kinase inhibitors in non–small-cell lung cancer patients. I...
作者:Hans Kreipe , Axel Haverich ...
来源:[J].The American Journal of Pathology(IF 4.522), 2015, Vol.185 (12), pp.3178-3188
摘要:Chronic lung allograft dysfunction (CLAD) is the main reason for poor long-term outcome of lung transplantation, with bronchiolitis obliterans (BO) representing the predominant pathological feature. BO is defined as a progressive fibrous obliteration of the small airways, th...
作者:... Henriette Christgen , Florian Länger , Hans Kreipe
来源:[J].Human Pathology(IF 2.843), 2015, Vol.46 (9), pp.1341-1349
摘要:Summary(#br)Therapeutic decision-making in breast cancer depends on histopathologic biomarkers and is influenced by the Ki67 proliferation index. Computer-assisted image analysis (CAIA) promises to improve Ki67 quantification. Several commercial applications have been develo...
作者:Hans Kreipe , Jens Panse ...
来源:[J].Leukemia Research(IF 2.764), 2015, Vol.39 (11), pp.1292-1298
摘要:Abstract(#br)Myelodysplastic syndrome (MDS) associated with an acquired, isolated deletion of chromosome 5q (del (5q) MDS), represent a clonal disorder of hematopoiesis and a clinically distinct entity of MDS. Treatment of del (5q) MDS with the drug lenalidomide has signific...
作者:... Oleg Gluz , Nadia Harbeck , Hans Kreipe
来源:[J].Pathology - Research and Practice(IF 1.213), 2016, Vol.212 (7), pp.583-597
摘要:Abstract(#br)Infiltrating lobular breast cancer (ILBC) is the most common special breast cancer subtype. This review provides a comprehensive description of ILBC characteristics, including epidemiology, clinical features, molecular genetics and histomorphology. Twenty detail...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×